Despite being the most common intraocular malignancy among adults, choroidal melanoma is a rare cancer type, even more so when accompanied by lung cancer.
Publications
FDA Orphan Drug Designation Granted to ST101 for Advanced Cutaneous Melanomas
The FDA granted a fast track designation to ST101 for the treatment of advanced cutaneous melanoma in patients who have disease progression on or after anti-PD-1/anti-PD-L1 therapy.
Melanoma detection during routine skin checks and mortality
Melanomas diagnosed during routine skin checks were identified to be related to significantly lower all-cause mortality, but not melanoma-specific mortality, post-adjustment for patient, sociodemographic, and clinicopathologic factors.
NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.